Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19. : H164-318/2021E-PDF
"This guidance applies to sponsors of new COVID-19 drug submissions as well as sponsors seeking a Notice of Compliance (NOC) for COVID-19 drugs that received temporary authorization under the Interim order respecting the importation, sale and advertising of drugs for use in relation to COVID-19 (ISAD IO). It also applies to new COVID-19 drug establishment licences under the Food and Drug Regulations. This document will help manufacturers prepare a submission for a Notice of Compliance for a COVID-19 drug under the Regulations. It also outlines the process for meeting the post-market regulatory requirements"--page 1.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.898414&sl=1
Ministère/Organisme | Canada. Health Canada, issuing body. |
---|---|
Titre | Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19. |
Type de publication | Monographie |
Langue | [Anglais] |
Autres langues publiées | [Français] |
Format | Électronique |
Document électronique | |
Note(s) | Issued also in French under title: Lignes directrices sur les modifications apportées au Règlement sur les aliments et drogues pour les médicaments contre la COVID-19. Includes bibliographical references (pages 30-31). |
Information sur la publication | [Ottawa] : Health Canada = Santé Canada, 2021. ©2021 |
Description | 1 online resource (iv, 32 pages) |
ISBN | 9780660383286 |
Numéro de catalogue |
|
Numéro de catalogue du ministère | 210010 |
Descripteurs | COVID-19 Pandemic, 2020- -- Health aspects -- Canada. Pharmaceutical policy -- Canada. |
Demander des formats alternatifs
Pour demander une publication dans un format alternatif, remplissez le formulaire électronique des publications du gouvernement du Canada. Utilisez le champ du formulaire «question ou commentaire» pour spécifier la publication demandée.- Date de modification :